BSE Live
Sep 09, 15:31Prev. Close
5144.15
Open Price
5105.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 09, 15:31Prev. Close
5143.50
Open Price
5141.00
Bid Price (Qty.)
5146.00 (1)
Offer Price (Qty.)
5149.00 (6)
Balance Sheet of Pfizer (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
Total Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
Reserves and Surplus | 4,171.66 | 3,549.79 | 3,161.55 | 2,818.66 | 2,347.29 | |
Total Reserves and Surplus | 4,171.66 | 3,549.79 | 3,161.55 | 2,818.66 | 2,347.29 | |
Total Shareholders Funds | 4,217.41 | 3,595.54 | 3,207.30 | 2,864.41 | 2,393.04 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 67.62 | 54.35 | 93.32 | 127.74 | 42.68 | |
Long Term Provisions | 56.57 | 32.33 | 42.76 | 55.47 | 55.84 | |
Total Non-Current Liabilities | 124.19 | 86.68 | 136.08 | 183.21 | 98.52 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | |
Trade Payables | 151.60 | 166.23 | 217.06 | 263.94 | 283.74 | |
Other Current Liabilities | 364.07 | 332.85 | 337.27 | 507.90 | 407.47 | |
Short Term Provisions | 51.34 | 44.98 | 100.52 | 78.55 | 80.63 | |
Total Current Liabilities | 569.51 | 546.56 | 657.35 | 852.89 | 774.34 | |
Total Capital And Liabilities | 4,911.11 | 4,228.78 | 4,000.73 | 3,900.51 | 3,265.90 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 171.82 | 150.95 | 177.53 | 218.92 | 192.38 | |
Intangible Assets | 551.80 | 561.76 | 571.72 | 622.04 | 672.36 | |
Capital Work-In-Progress | 7.64 | 0.40 | 7.93 | 1.15 | 2.76 | |
Other Assets | 0.00 | 0.00 | 0.00 | 28.17 | 29.56 | |
Fixed Assets | 731.26 | 713.11 | 757.18 | 870.28 | 897.06 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 69.30 | 53.94 | 97.67 | 46.98 | 13.46 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.40 | 32.31 | |
Other Non-Current Assets | 597.70 | 692.17 | 620.79 | 586.37 | 398.36 | |
Total Non-Current Assets | 1,398.26 | 1,459.22 | 1,475.64 | 1,504.03 | 1,341.19 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 475.92 | 433.69 | 417.70 | 448.90 | 435.05 | |
Trade Receivables | 193.09 | 187.61 | 151.73 | 124.27 | 129.69 | |
Cash And Cash Equivalents | 2,800.98 | 2,046.71 | 1,859.52 | 1,633.33 | 1,115.10 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.26 | 8.56 | |
OtherCurrentAssets | 42.86 | 101.55 | 96.14 | 189.72 | 236.31 | |
Total Current Assets | 3,512.85 | 2,769.56 | 2,525.09 | 2,396.48 | 1,924.71 | |
Total Assets | 4,911.11 | 4,228.78 | 4,000.73 | 3,900.51 | 3,265.90 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 364.73 | 533.83 | 437.83 | 338.14 | 254.98 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 596.03 | 520.19 | 0.84 | 0.00 | 0.51 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 113.99 | 84.76 | 68.78 | 78.13 | 33.92 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
14.08.2025
14.08.2025
03.07.2025
22.05.2025
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
30.07.2024
Pfizer Standalone June 2024 Net Sales at Rs 562.86 crore, up 5.93% Y-o-Y
20.05.2024
Pfizer Standalone March 2024 Net Sales at Rs 546.63 crore, down 4.54% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011